Dear Colleagues,
In collaboration with the journal Biomedicines (Impact factor 6.081), I organize the Topical Collection « Feature Papers in Gene and Cell Therapy« , which is now open for submission of manuscripts. The full description can be found here: https://www.mdpi.com/journal/biomedicines/special_issues/Gene_Therapy_Cell_Therapy
The aim of this project is to bring together international experts to provide a comprehensive overview about this dynamic research field. Therefore, I invite you to participate with either an original article or a review focused on some aspects of the subject.
*There is no submission deadline for this Topical Collection.* Submitted manuscripts will be processed immediately upon receipt and published online upon acceptance. I guarantee a fair review process for all manuscripts submitted to my Topical Collection.
Benefits when publishing with Biomedicines:
1. Open access.
2. High visibility: Biomedicines is indexed by SCIE, PubMed, and Scopus. Biomedicines has received an updated Impact Factor of 6.081 in the June 2021 release of the Journal Citation Reports (+28.9% compared with the previous year). Biomedicines now ranks 32 out of 140 (Q1) titles in the ‘Medicine, Research & Experimental’ category, 32 out of 275 (Q1) titles in ‘Pharmacology & Pharmacy’, as well as 65 out of 298 (Q1) titles in ‘Biochemistry & Molecular Biology’.
3. Rapid publication times upon acceptance.
4. Low article processing charge (APC) of CHF 2200 for all accepted manuscripts in 2022 (see updates at https://www.mdpi.com/journal/biomedicines/apc).
1. Open access.
2. High visibility: Biomedicines is indexed by SCIE, PubMed, and Scopus. Biomedicines has received an updated Impact Factor of 6.081 in the June 2021 release of the Journal Citation Reports (+28.9% compared with the previous year). Biomedicines now ranks 32 out of 140 (Q1) titles in the ‘Medicine, Research & Experimental’ category, 32 out of 275 (Q1) titles in ‘Pharmacology & Pharmacy’, as well as 65 out of 298 (Q1) titles in ‘Biochemistry & Molecular Biology’.
3. Rapid publication times upon acceptance.
4. Low article processing charge (APC) of CHF 2200 for all accepted manuscripts in 2022 (see updates at https://www.mdpi.com/journal/biomedicines/apc).
Additionally, we are glad to provide 200 CHF discount for each invited submission.
Please do not hesitate to contacts me or the editorial office (Ms. Jemma Ai jemma.ai@mdpi.com) for further information. We look forward to hearing from you soon.
Best regards,
Bernard Lebleu
Emeritus Professor Université Montpellier
Collection Editor, Section Editor-in-Chief, Biomedicines
